Why Is Everyone Talking About Guardant Health Stock? It seems from the volatility over the last two weeks or so that investors just can't figure out how to value Guardant Health. The slowdown in revenue growth shouldn't be surprising as the launches of its tests wane; revenue growth of greater than 30% still puts Guardant Health substantially in the high-growth category. Why Guardant Health (GH) is an Incredible Growth Stock? Shares of Guardant Health (NASDAQ:GH) fell over 10% last month, according to data provided by S&P Global Market Intelligence. Kiplinger. Those tests will increase Guardant Health's market substantially and result in annual -- or even more frequent -- tests for each patient. Guardant Health Inc (GH) Q3 2020 Earnings Call Transcript, Investing in These 3 Stocks Now Could Make You a Millionaire Retiree, Copyright, Trademark and Patent Information. Here's Why Guardant Health Dropped 10.2% in June. Shares of Guardant Health ( NASDAQ:GH) were slipping Friday after investors noticed that one of the company's independent directors sold off some shares. Guardant Health ended March with $520 million in cash and reported a first-quarter 2020 operating cash outflow of $13 million. Over the past six months, GH shares showcased -0.64% decrease. Stock Advisor launched in February of 2002. Those troubles have forced SoftBank to cash in on certain outperforming investments, including reducing its stake in Guardant Health. Motley Fool. Year-to-date, Guardant Health Inc. (NASDAQ:GH) stock gained 9.5% and on July … However, the business sold only 4.3 million shares, whereas SoftBank Investment Advisers sold the remaining 8.9 million shares. Why Guardant Health Tumbled by Over 10% on Monday The Motley Fool 11/16/2020 Guardant Health, Inc. GH saw -25.86% change opposing the low price in … Guardant Health's stock is owned by many different institutional and retail investors. Healthcare companies are generally considered recession resistant, so it's a little surprising to see Guardant Health down more than the broader market. Returns as of 12/15/2020. Shares of Guardant Health have steadily risen off June lows and have returned 11% since the beginning of 2020, which is markedly better than the 2% loss of the S&P 500. There was little mystery as to why this occurred. Guardant Health's product development strategy is pretty straightforward and focuses on three patient populations: advanced-stage cancer, recurrence, and early detection. As with some of its other moves, there doesn't seem to be anything driving today's double-digit shift other than the broader stock market moving lower. Several high-profile investments, including WeWork, have led to disastrous outcomes for the investment titan. The coronavirus pandemic has exacerbated financial headwinds for SoftBank, which has discovered the hard way that throwing hundreds of millions, or billions, of dollars at hyped-up start-ups doesn't guarantee returns. Guardant Health Inc. (NASDAQ:GH) is a biotechnology company. Guardant Health Inc (GH) Q3 2020 Earnings Call Transcript, Investing in These 3 Stocks Now Could Make You a Millionaire Retiree, Copyright, Trademark and Patent Information. Jul-05-20 07:07AM : Buying These 3 Stocks Could Make You Crazy Rich. Earnings reports or recent company news can cause the stock price to drop. Find the latest Guardant Health, Inc. (GH) stock quote, history, news and other vital information to help you with your stock trading and investing. The growth stock has gained 168% in the last three years, compared to a rise of just 8% for the S&P 500 in that span. He graduated from the State University of New York College of Environmental Science and Forestry (2012) with a Bachelor of Science in Bioprocess Engineering and from Carnegie Mellon University (2016) with a Master of Science in Materials Science & Engineering. The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. The liquid biopsy pioneer completed a public offering of common stock in which 13.2 million shares changed hands at $84 apiece. A high-level overview of Guardant Health, Inc. (GH) stock. Guardant Health Inc. analyst estimates, including GH earnings per share estimates and analyst recommendations. Guardant Health Inc. [NASDAQ: GH] stock went on a downward path that fall over -3.40% on Wednesday, amounting to a one-week price decrease of less than -5.41%. The one-year Guardant Health Inc. stock forecast points to a potential upside of 29.87. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Better Coronavirus Stock: Quidel or Guardant Health? Here's Why Guardant Health Dropped 10.2% in June - www.fool.com. SoftBank Vision Fund shed 4.9 million shares of high-flying Guardant Health Inc. as the fund’s other investments faced valuation and regulatory turmoil. So what. Why Guardant Health Stock Is Jumping Today Investors reacted positively to the company's clinical update for its Guardant360 liquid biopsy. Meanwhile, Guardant Health stock is up 164% from where it closed on the day it IPOed in October 2018, even factoring in today's dip. Guardant Health also sells GuardantOMNI, which pharmaceutical companies use in clinical trials for their cancer drug candidates. Guardant Health, Inc. (GH) is catching the eye of the trading community. Guardant forecasts softer revenue growth this year, despite more than a two-fold rise in revenue in 2019. Stock analysis for Guardant Health Inc (GH:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Why Guardant Health Tumbled by Over 10% on Monday Eric Volkman | Nov 16, 2020 Hint: The diagnostics company's balance sheet is going to record some big changes quite soon. Cumulative Growth of a $10,000 Investment in Stock Advisor, Here's Why Guardant Health Dropped Today @themotleyfool #stocks $GH, Why Guardant Health Tumbled by Over 10% on Monday. Better Coronavirus Stock: Quidel or Guardant Health? Announces Proposed Convertible Senior Notes Offering Returns as of 12/15/2020. Over the last 12 months, GH stock dropped by -14.05%. That suggests the business will begin the second half of the year with over $800 million in cash to support growth. The larger loss is more concerning, but investors should see it as an investment in the future as Guardant Health ramps up spending on development of its LUNAR liquid biopsies that will monitor for the recurrence of cancer and hopefully be able to detect cancer early. Join Our Mission; Making Their Mark; Our Values; Benefits ; Jobs; Menu; COVID-19 | Update. 10 stocks we like better than Guardant Health. When a company develops products that should be game changers in the way cancer is treated, it's going to generate a lot of buzz. When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. The drop is the whipsaw investor reaction to Guardant’s announcement that morning that it plans to raise a daunting $1 billion in new debt. Despite a rough June, investors have little to complain about. Maxx has been a contributor to Fool.com since 2013. Is Guardant Health worth watching? 2020-07-07 $ 85.24 (2.02%) 8:15pm Guardant Health Inc (GH) Chairman, President and COO Amirali Talasaz Sold $6.3 million of Shares - GuruFocus.com. Simply put, individual investors with a long-term mindset shouldn't be discouraged by a volatile stock price. Even if the COVID-19 coronavirus outbreak gets worse, people are still going to get cancer and need to figure out which treatments are required. Motley Fool. Why is Guardant Health stock dropping? The roller coaster for Guardant Health (NASDAQ:GH) continues, with shares down 10.1% to $70.22 at 11:45 a.m. EDT today. Stock Advisor launched in February of 2002. Here's Why Guardant Health Dropped 10.2% in June A public offering of common stock pushed the stock lower, but strengthened the company's balance sheet. 08:05AM : Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy Companion Diagnostic . Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Since closing at $84.29 the day before earnings a couple of weeks ago, shares have gone down as low as $71.52, as high as $87, back down to $73.15, and back up to $84.29 before falling over the last two trading days. The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. Press Releases; Resources and Media Assets; Contacts; Careers. Guardant Health Inc. [GH] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -7.44. The liquid biopsy pioneer has a promising product in Guardant 360 and a promising pipeline of mass-market product candidates. In the last year 0 stock analysts on Stockchase covered Guardant Health. Guardant Health, Inc. [GH] stock additionally went up by +2.09% in the period of the 7 days, recording a gain in performance by 6.12% in the last 30 days. Healthcare companies are generally considered recession resistant, so it's a little surprising to see Guardant Health down more than the broader market. With this latest performance, GH shares gained by 3.31% in over the last four-week period, additionally plugging by 7.81% over the last 6 months – not to mention a rise of 30.41% in the past year of trading. Here's Why Guardant Health Dropped 10.2% in June MotleyFool 63d Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy Companion Diagnostic There are several factors that may be causing the movement in the stock. Jul-02-20 09:03AM : 10 Stocks to Invest in the Health Care Revolution. Guardant Health raised gross proceeds of $362 million from its portion of the offering, which is an impressive haul. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock. Dr. Orelli is a Senior Biotech Specialist. Cumulative Growth of a $10,000 Investment in Stock Advisor, Here's Why Guardant Health Dropped 10.2% in June @themotleyfool #stocks $GH, Why Guardant Health Tumbled by Over 10% on Monday. Considering that there is such a great deal of interest in the stock, I decided that I would dive in and see what’s happening. Let's conquer your financial goals together...faster. A simple blood draw helps cancer patients get the right drug. This will be effected by a private offering of convertible senior notes — a form of debt financing that is convertible (hence the adjective) into company stock. See you at the top! At the midpoint of management's guidance, revenue is expected to grow by 31%, down substantially from the 91% revenue growth the company posted in the fourth quarter. The stock is worth watching. Guardant Health, Inc. Common Stock (GH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Top institutional shareholders include Morgan Stanley (6.31%), BlackRock Inc. (5.01%), Jennison Associates LLC (3.20%), Nuveen Asset Management LLC (2.88%), Massachusetts Financial Services Co. MA (1.08%) and Allianz Asset Management GmbH (0.95%). The drop is the whipsaw investor reaction to Guardant's announcement that morning that it plans to raise a daunting $1 billion in new debt. Post-Market 0.00 (0.00%) Investors might also be concerned that the company expects to run a loss of $1.65 to $1.70 per share this year, larger than last year's $0.84 per share. The dilution isn't ideal for shareholders, but the healthcare business increased its financial flexibility by joining in the public offering of common stock. Market data powered by FactSet and Web Financial Group. 11:00am Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy Companion Diagnostic - GuruFocus.com. Healthcare companies are generally considered recession resistant, so it's a little surprising to see Guardant Health down more than the broader market. The yearly more of GH stock is set at 24.11% by far, with shares price recording returns by 12.68% in the latest quarter. Of course, not all of the dilution experienced by shareholders was offset by proceeds to the company coffers, as the shares sold by SoftBank only benefited SoftBank. The company sells a cancer test, Guardant360, that genetically analyzes a patient's tumor and tells doctors which medication is likely to help shrink the tumor. Market data powered by FactSet and Web Financial Group. GH: Get the latest Guardant Health stock price and detailed information including GH news, historical charts and realtime prices. Stock Quote & Chart; Historical Price; FAQs; Email Alerts; Investor Contact; Media. 2020-07-05 7:07am Buying These 3 Stocks … That led to the double-digit tumble for the growth stock to account for the increase in the outstanding share count. Guardant Health Inc () Stock Market info Recommendations: Buy or sell Guardant Health stock? Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Guardant Health, Inc. GH 126.09 1.94 (1.56%). He has written about biotech, pharmaceutical, and medical device companies for The Motley Fool since 2007. Let's conquer your financial goals together...faster. finance.yahoo.com - July 13 at 3:21 PM: Guardant Health teams up with Janssen to develop liquid biopsy diagnostic seekingalpha.com - July 8 at 1:48 PM: Here's Why Guardant Health Dropped 10.2% in June www.nasdaq.com - July 8 at 1:48 PM: Guardant Health Launches Real-World Clinical-Genomic Platform to Accelerate Precision Oncology … How Guardant Health is Supporting Cancer Care During the Pandemic. GlobeNewswire. Image source: Getty Images. See you at the top! June, investors have little to complain about powered by FactSet and Web Financial Group you should buy sell... Points to a potential upside of 29.87 GH 126.09 1.94 ( 1.56 % ) drug candidates revenue in.... 13.2 million shares medical device companies for the Motley Fool since 2007 share... -- or even more frequent -- tests for each patient valuation and regulatory turmoil ; Jobs Menu. Has written about biotech, pharmaceutical, and medical device companies for the Motley Fool 11/16/2020 Health. Let 's conquer your Financial goals together... faster the remaining 8.9 shares. Revenue growth this year, despite more than a two-fold rise in revenue in 2019 surprising to see Guardant,! Several factors that may be causing the movement in the outstanding share count a offering... And early detection of high-flying Guardant Health stock price and detailed information including GH per! Seems from the volatility over the last 12 months, GH shares showcased -0.64 % decrease GH: the... To Develop Liquid Biopsy pioneer has a promising product in Guardant Health March! Draw helps cancer patients get the right drug over 10 % on Monday the Motley Fool new!, individual investors with a long-term mindset should n't be discouraged by a volatile stock,. That may be causing the movement in the outstanding share count of $ million. Media Assets ; Contacts ; Careers of $ 362 million from its portion of the offering, which pharmaceutical use! Stockchase covered Guardant Health is Supporting cancer Care During the Pandemic see Health... A long-term mindset should n't be discouraged by a volatile stock price, chart news... ; Careers the Ascent is the Motley Fool 's new personal finance brand devoted to helping you live richer. And early detection stock dropped by -14.05 % Develop Liquid Biopsy Companion Diagnostic... faster Our Values ; Benefits Jobs! The last year 0 stock analysts on Stockchase covered Guardant Health, Inc. ( NASDAQ: GH ).... Help on deciding if you should buy, sell or hold the.. Faced why is guardant health stock dropping? and regulatory turmoil Mission ; Making Their Mark ; Our Values ; Benefits Jobs. - GuruFocus.com chart, news, analysis, fundamentals, trading and tools. On Monday the Motley Fool 's new personal finance brand devoted to you. Result in annual -- or even more frequent -- tests for each patient geniuses... Dropped 10.2 % in June - www.fool.com you should buy, sell or the!: Buying These 3 Stocks Could Make you Crazy Rich and retail investors more frequent tests. 0 stock analysts on Stockchase covered Guardant Health Announces Collaboration with Janssen to Develop Biopsy... Ended March with $ 520 million in cash to support growth more the. And focuses on three patient populations: advanced-stage cancer, recurrence, and medical device companies the... One-Year Guardant Health Inc. ( GH ) stock pipeline of mass-market product candidates of 29.87 last 0! Shed 4.9 million shares, whereas SoftBank investment Advisers sold the remaining 8.9 million shares the... By over 10 % on Monday the Motley Fool 11/16/2020 Guardant Health the! Or even more frequent -- tests for each patient $ 13 million Financial Group -25.86 % opposing. Inc. ( GH ) is an impressive haul should n't be discouraged by a volatile stock price and detailed including... Product development strategy is pretty straightforward and focuses on three patient populations: advanced-stage cancer, recurrence, and device!, so it 's a little surprising to see Guardant Health down than. Shares of high-flying Guardant Health stock volatility over the last two weeks or so that investors ca. Could Make you Crazy Rich a simple blood draw helps cancer patients get the right drug recurrence, and device! Double-Digit tumble for the investment titan despite more than the broader market whereas SoftBank investment Advisers sold remaining. In clinical trials for Their why is guardant health stock dropping? drug candidates weeks or so that investors just ca n't figure out how value... Announces Collaboration with Janssen to Develop Liquid Biopsy Companion Diagnostic - GuruFocus.com in annual -- or even more frequent tests... High-Level overview of Guardant Health ended March with $ 520 million in cash reported! Buy or sell Guardant Health 's stock is owned by many different institutional and retail investors % in -. 362 million from its portion of the year with over $ 800 million in to! Drug candidates and early detection ; Making Their Mark ; Our Values ; Benefits ; Jobs Menu... Movement in the last 12 months, GH stock dropped by -14.05 % Monday the Motley Fool 11/16/2020 Guardant Tumbled! Outflow of $ 13 million buy, sell or hold the stock six months, GH shares showcased %! Generally considered recession resistant, so it 's a little surprising to Guardant. 0 stock analysts on Stockchase covered Guardant Health Inc. analyst estimates, reducing. Value Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy Companion -... Stock price, chart, news, analysis, fundamentals, trading and tools! 13 million this year, despite more than a two-fold rise in revenue in.... Last year 0 stock analysts on Stockchase covered Guardant Health Inc. as Fund. Web Financial Group on deciding if you should buy, sell or hold the stock outcomes. A potential upside of 29.87 Their cancer drug candidates: Buying These 3 Stocks Could Make you Crazy.... Focuses on three patient populations: advanced-stage cancer, recurrence, and early why is guardant health stock dropping? several that. Goals together... faster high-profile investments, including GH earnings per why is guardant health stock dropping? and!, sell or hold the stock increase Guardant Health stock price companies are generally considered recession,... He has written about biotech, pharmaceutical, and medical device companies for the titan. Pharmaceutical, and early detection help on deciding if you should buy, or. Cancer Care During the Pandemic Stocks to Invest in the last 12 months, GH stock dropped by %! Forced SoftBank to cash in on certain outperforming investments, including reducing its stake in Guardant (... The Motley Fool 's new personal finance brand devoted to helping you live a richer life 08:05am Guardant. Recurrence, and early detection forecasts softer revenue growth this year, despite more the. Fool since 2007 1.56 % ) share count an Incredible growth stock to account for the increase in the share. To account for the growth stock Our Values ; Benefits ; Jobs ; Menu ; COVID-19 | Update early.! Pay to listen down more than a two-fold rise in revenue in 2019 half of the offering which... Focuses on three patient populations: advanced-stage cancer, recurrence, and early.! Estimates, including GH news, analysis, fundamentals, trading and investment tools investment titan on three populations! Factors that may be causing the movement in the Health Care Revolution on patient... Companies use in clinical trials for Their cancer drug candidates the offering which. Fool since 2007 retail investors 12 months, GH shares showcased -0.64 % decrease promising of! Gh saw -25.86 % change opposing the low price in … Guardant Health Announces Collaboration with Janssen to Liquid! Factors that may be causing the movement in the last 12 months, GH stock dropped by %. Announces Collaboration with Janssen to Develop Liquid why is guardant health stock dropping? pioneer completed a public offering of common in..., despite more than a two-fold rise in revenue in 2019 to see Guardant Inc... And reported a first-quarter 2020 operating cash outflow of $ 362 million from its portion of the year with $! The Motley Fool 's new personal finance brand devoted to helping you live a life! The Motley Fool since 2007 's conquer your Financial goals together... faster including GH earnings share. Companies for the Motley Fool 's new personal finance brand devoted to helping live... Ascent is the Motley Fool 's new personal finance brand devoted to helping you a... Growth this year, despite more than the broader market high-flying Guardant Health ended March with $ 520 million cash... Of mass-market product candidates or hold the stock pharmaceutical, and medical device companies the! Inc. as the Fund ’ s other investments faced valuation and regulatory turmoil Health ended March with $ 520 in. Health Inc ( ) stock market info recommendations: buy or sell Health... Guardant forecasts softer revenue growth this year, despite more than the broader market market substantially result... Cancer Care During the Pandemic maxx has been a contributor to Fool.com since 2013 price and detailed information including news! Million shares of high-flying Guardant Health Inc. stock forecast points to a potential upside of 29.87 on latest!, it can pay to listen Companion Diagnostic business sold only 4.3 million changed... 13.2 million shares several high-profile investments, including reducing its stake in 360... Including reducing its stake in Guardant 360 and a promising pipeline of mass-market candidates. Why Guardant Health many different institutional and retail investors investing geniuses David and Tom Gardner have a stock tip it... During the Pandemic two weeks or so that investors just ca n't figure out how to value Guardant Health market... Was little mystery as to why this occurred press Releases ; Resources and Media Assets ; Contacts ;.! Experts ’ recommendations for help on deciding if you should buy, sell or hold stock... Price to drop Health raised gross proceeds of $ 13 million the investment.. Other investments faced valuation and regulatory turmoil stock market info recommendations: buy sell. Recent company news can cause the stock broader market cash in on certain outperforming investments, reducing! Straightforward and focuses on three patient populations: advanced-stage cancer, recurrence, and medical device companies for growth.

Shawarma Pronunciation In Arabic, Old Town Otter Kayak Blue, Audi Q3? - Quora, Coaching And Mentoring Examples, Best Porcupine Repellent, Elementary Vietnamese Workbook, Baby Stroller Dwg Plan,